Activation of α7-nAChRs Promotes the Clearance of α-Synuclein and Protects Against Apoptotic Cell Death Induced by Exogenous α-Synuclein Fibrils.

作者: Yi Fan , Ji Zhang , Shi Xu , Tingting Tao , Yun Li

DOI: 10.3389/FCELL.2021.637319

关键词:

摘要: Misfolding and abnormal aggregation of α-synuclein (αSyn) have been shown to increase the risk developing Parkinson's disease (PD). Finding some way reduce αSyn is particularly important for treatment PD. The main route in prion-like spreading cholinergic innervated vagus nervous system central neurons. Since degenerative changes death neurons also run through pathological process PD, we hypothesize an involvement aggregation. α7 nicotinic acetylcholine receptors (α7-nAChRs) are one most abundant nAChRs mammalian brain. Using nicotine a selective α7-nAChRs agonist PNU-282987, found protective effect on cell damage induced by αSyn-PFF (preformed fibrils) inhibiting apoptotic death. We further discovered additive clearance normal stably transduced SH-SY5Y cells. Moreover, using knockout mice, noticed that deficiency increased deposition aggravated loss dopaminergic chronic MPTP mouse model Our findings first time indicated activation exhibited neuroprotective pathology promoting αSyn.

参考文章(49)
Alvin Djajadikerta, Swati Keshri, Mariana Pavel, Ryan Prestil, Laura Ryan, David C. Rubinsztein, Autophagy induction as a therapeutic strategy for neurodegenerative diseases Journal of Molecular Biology. ,vol. 432, pp. 2799- 2821 ,(2020) , 10.1016/J.JMB.2019.12.035
Maryka Quik, Danhui Zhang, Matthew McGregor, Tanuja Bordia, Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease. Biochemical Pharmacology. ,vol. 97, pp. 399- 407 ,(2015) , 10.1016/J.BCP.2015.06.014
Maryka Quik, Danhui Zhang, Xiomara A. Perez, Tanuja Bordia, Role for the nicotinic cholinergic system in movement disorders; therapeutic implications Pharmacology & Therapeutics. ,vol. 144, pp. 50- 59 ,(2014) , 10.1016/J.PHARMTHERA.2014.05.004
Eric S. Luth, Irina G. Stavrovskaya, Tim Bartels, Bruce S. Kristal, Dennis J. Selkoe, Soluble, prefibrillar α-synuclein oligomers promote complex I-dependent, Ca2+-induced mitochondrial dysfunction. Journal of Biological Chemistry. ,vol. 289, pp. 21490- 21507 ,(2014) , 10.1074/JBC.M113.545749
J. Burre, M. Sharma, T. Tsetsenis, V. Buchman, M. R. Etherton, T. C. Sudhof, α-Synuclein promotes SNARE-complex assembly in vivo and in vitro Science. ,vol. 329, pp. 1663- 1667 ,(2010) , 10.1126/SCIENCE.1195227
E. Colla, P. H. Jensen, O. Pletnikova, J. C. Troncoso, C. Glabe, M. K. Lee, Accumulation of toxic α-synuclein oligomer within endoplasmic reticulum occurs in α-synucleinopathy in vivo. The Journal of Neuroscience. ,vol. 32, pp. 3301- 3305 ,(2012) , 10.1523/JNEUROSCI.5368-11.2012
Wassilios G Meissner, Mark Frasier, Thomas Gasser, Christopher G Goetz, Andres Lozano, Paola Piccini, José A Obeso, Olivier Rascol, Anthony Schapira, Valerie Voon, David M Weiner, François Tison, Erwan Bezard, None, Priorities in Parkinson's disease research Nature Reviews Drug Discovery. ,vol. 10, pp. 377- 393 ,(2011) , 10.1038/NRD3430
Latha Devi, Vijayendran Raghavendran, Badanavalu M. Prabhu, Narayan G. Avadhani, Hindupur K. Anandatheerthavarada, Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain Journal of Biological Chemistry. ,vol. 283, pp. 9089- 9100 ,(2008) , 10.1074/JBC.M710012200